Supplementary table S3 from Patient-Derived Xenografts from Non–Small Cell Lung Cancer Brain Metastases Are Valuable Translational Platforms for the Development of Personalized Targeted Therapy

MLA

Do-Hyun Nam, et al. Supplementary Table S3 from Patient-Derived Xenografts from Non–Small Cell Lung Cancer Brain Metastases Are Valuable Translational Platforms for the Development of Personalized Targeted Therapy. Mar. 2023. EBSCOhost, https://doi.org/10.1158/1078-0432.22460823.

APA

Do-Hyun Nam, Kyeung Min Joo, Young Mog Shim, Ho Jun Seol, Hyun Moo Lee, Woong-Yang Park, Yoon-La Choi, Yong-Jun Kwon, Je-Gun Joung, Sang Shin, Yun Jee Seo, Da Eun Jeong, Hye Jin Song, Hyun Jung Cho, Se Jeong Lee, Jung-il Lee, & Hye Won Lee. (2023). Supplementary table S3 from Patient-Derived Xenografts from Non–Small Cell Lung Cancer Brain Metastases Are Valuable Translational Platforms for the Development of Personalized Targeted Therapy. https://doi.org/10.1158/1078-0432.22460823

Chicago

Do-Hyun Nam, Kyeung Min Joo, Young Mog Shim, Ho Jun Seol, Hyun Moo Lee, Woong-Yang Park, Yoon-La Choi, et al. 2023. “Supplementary Table S3 from Patient-Derived Xenografts from Non–Small Cell Lung Cancer Brain Metastases Are Valuable Translational Platforms for the Development of Personalized Targeted Therapy,” March. doi:10.1158/1078-0432.22460823.